ARCHIVES

DePinho’s Letter to CPRIT’s Gimson, And Gimson’s Response

This article is from The Cancer Letter archive.

Vol. 38 No. 22 | June 1, 2012

Download PDF Visit The Full Archive

Related Articles

ASCO, FDA Website To Help Demystify Expanded Access

June 25, 2010

Did Iressa Data Merit Approval? Experts Discuss Implications For Drug Development, Lung Cancer Treatment, Reimbursement (12-page issue).

May 9, 2003

NCI To Test 5,000 DC-Area Jews To Determine Risk Of BRCA 1 Mutation

October 6, 1995

Phase III Trebananib Trial Fails OS Endpoint In Recurrent Platinum-Resistant Ovarian Cancer

November 28, 2014

Velcade Plus Dexamethasone Provides 20% Response In First-Line Treatment

December 29, 2006

UNM Gets $1.8 Million For Nanotechnology Center

February 18, 2011